3aZEVvoRtp6McXy8TuIlR6lERn067Z

Investor Relations

NYSE: NVRO

Price

63.02 +1.50 ( +2.44% ) 4:02 7/23/19 Pricing delayed 20 minutes

Volume 169,219

Recent News

See All
July 15, 2019 ­Nevro to Report Second Quarter 2019 Financial Results
Company to Host Conference Call on Thursday, August 8, 2019 at 1:30 p.m. PT / 4:30 p.m. ET Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the second quarter ended June 30, 2019 after the market closes on August 8, 2019. Investors interested in listening to the conference call may do so by dialing (833) 286-5807 in the U.S. or (647) 689-4452 internationally, using Conference ID: 1694716.  In addition, a live webcast, as well as an archived recording, will be available on the "Investors" section of the Company's website at: www.nevro.com. About Nevro Corp.
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the...
June 25, 2019 Nevro Announces Executive Appointments
Names Niamh Pellegrini as Chief Commercial Officer and Lori Ciano as Chief Human Resources Officer Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointments of two senior executives to the Company's leadership team.  Ms. Niamh Pellegrini has been named Chief Commercial Officer, responsible for all global sales and marketing-related activities, and Ms. Lori Ciano has been named Chief Human Resources Officer.  Ms. Pellegrini and Ms. Ciano will report directly to D. Keith Grossman, Chairman, CEO and President. "We are excited to have such proven and experienced professionals join the Nevro executive team to lead two of our highest priorities - serving our customers and our people.  Niamh will lead and coordinate the efforts of our talented commercial leadership team in order to execute our commercial strategies and drive sales growth.  Lori will work to develop our...
June 11, 2019 Nevro to Present at BMO 2019 Prescriptions for Success Healthcare Conference
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the Company will be participating in the BMO 2019 Prescriptions for Success Healthcare Conference in New York City . Nevro Chairman, CEO and President D. Keith Grossman is scheduled to present on Tuesday, June 25, 2019 at 11:20 am Eastern Time. A live webcast of the presentation, as well as an archived recording, will be available on the "Investors" section of the Company's website at www.nevro.com. About Nevro Corp.
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza®...

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the SENZA® spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The SENZA® system is the only SCS system that delivers Nevro's proprietary HF10™ therapy. Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro.

Senza, Senza II, HF10, More, Nevro, Nevrocloud, Surpass and the Nevro, HF10, and Frequency Pairing Logos are trademarks of Nevro Corp.